 |
Kekst CNC represents Avista Capital Partners as the private equity firm acquires the dermatology and topicals business of G&W Laboratories.
The addition of G&W Dermatology to ACP’s investment portfolio is part of its strategy to “identify attractive niche healthcare assets and then acquire such businesses via a carve-out transaction,” according to Sriram Venkataraman, Avista partner.
Avista has named Walt Kaczmarek, a 25-year veteran of the pharmaceuticals sector, CEO of G&W Dermatology.
Carl Greenblatt, a pharmacist who served with the US Army during WWI, founded G&W Laboratories in 1919 His son, Burton, also a pharmacist, joined the company after he returned from service during WWII. A fourth-generation Greenblatt, Aaron, currently helms the company.
Kekst CNC’s Daniel Yunger, Sherri Toub and Daniel Hoadley represent Avista, which has more than $6B invested in 30 health-oriented businesses.
Publicis Groupe owns Kekst CNC.
Prosek Partners handles New York’s Tilray Brands, craft beer & cannabis operation, as it acquires BrewDog, a leading British independent beer producer in the UK, for $45M.
Brunswick Group handles Zurich Insurance as it agrees to buy UK-based Beazley specialty insurer in a deal valued at $11B.
FGS Global represents Brink’s as it agrees to acquire NCR Atleos, which relies on Collected Strategies, in a $6.6B cash & stock deal to create a leading fintech infrastructure company. (Updated)
A January article in O’Dwyer’s proposes that in 2026, the strongest financial brands will not simply tell compelling stories—they will “signal readiness.”
C Street Advisory Group is working the Chapter 11 filing of Axip Energy Services as it unloads its nearly all of its assets to deal with a heavy debt load.
